Læknablaðið - 15.10.2009, Side 43

8. Brown LM, McCarron P, Freedman DM. New Malignancies
Following Cancer of the Buccal Cavity and Pharynx.
In: Curtis RE, Freedman DM, Ron E, et alv eds. New
Malignancies Among Cancer Survivors: SEER Cancer
Registries, 1973-2000. Bethesda, MD: National Cancer
Institute, NIH Publ. No. 05-5302.; 2006:15-57.
9. Caporaso NE, Dodd KW, Tucker MA. New Malignancies
Following Cancer of the Respiratory Tract. In: Curtis RE,
Freedman DM, Ron E, et al., eds. New Malignancies Among
Cancer Survivors: SEER Cancer Registries, 1973-2000.
Bethesda, MD: National Cancer Institute, NIH Publ. No. 05-
5302.; 2006:145-79.
10. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study
of human papillomavirus and oropharyngeal cancer. N Engl
J Med 2007; 356:1944-56.
11. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human
papillomavirus types in head and neck squamous cell
carcinomas worídwide: a systematic review. Cancer
Epidemiol Biomarkers Prev 2005; 14:467-75.
12. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML.
Incidence trends for human papillomavirus-related and
-unrelated oral squamous cell carcinomas in the United
States. J Clin Oncol 2008; 26: 612-9.
13. Fakhry C, Westra WH, Li S, et al. Improved survival of
patients with human papillomavirus-positive head and neck
squamous cell carcinoma in a prospective clinical trial. J Natl
Cancer Inst 2008; 100: 261-9.
14. Hujala K, Sipila J, Grenman R. Panendoscopy and
synchronous second primary tumors in head and neck
cancer patients. Eur Arch Otorhinolaryngol 2005; 262:17-20.
15. Haughey BH, Gates GA, Arfken CL, Harvey J. Meta-analysis
of second malignant tumors in head and neck cancer: the
case for an endoscopic screening protocol. Ann Otol Rhinol
Laryngol 1992; 101:105-12.
16. Roh JL, Kim JS, Lee JH, et al. Utility of combined (18)F-
fluorodeoxyglucose-positron emission tomography and
computed tomography in patients with cervical metastases
from unknown primary tumors. Oral Oncol 2008.
17. Mendenhall WM, Mancuso AA, Amdur RJ, Stringer SP,
Villaret DB, Cassisi NJ. Squamous cell carcinoma metastatic
to the neck from an unknown head and neck primary site.
Am J Otolaryngol 2001; 22: 261-7.
18. Loh KS, Brown DH, Baker JT, Gilbert RW, Gullane PJ, Irish
JC. A rational approach to pulmonary screening in newly
diagnosed head and neck cancer. Head Neck 2005; 27: 990-
4.
19. Garcia C, Flamen P. Role of positron emission tomography
in the management of head and neck cancer in the molecular
therapy era. Curr Opin Oncol 2008; 20: 275-9.
20. Scott AM, Gunawardana DH, Bartholomeusz D, Ramshaw
JE, Lin P. PET changes management and improves prognostic
stratification in patients with head and neck cancer: results
of a multicenter prospective study. J Nucl Med 2008; 49:
1593-600.
21. Yao M, Smith RB, Graham MM, et al. The role of FDG PET in
management of neck metastasis from head-and-neck cancer
after definitive radiation treatment. Int J Radiat Oncol Biol
Phys 2005; 63: 991-9.
22. Wong RJ. Current status of FDG-PET for head and neck
cancer. J Surg Oncol 2008; 97: 649-52.
23. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging
Manual. Springer, New York 2002.
24. Grandi C, Alloisio M, Moglia D, et al. Prognostic significance
of lymphatic spread in head and neck carcinomas:
therapeutic implications. Head Neck Surg 1985; 8: 67-73.
25. Westin T, Stalfors J. Tumour boards/multidisciplinary head
and neck cancer meetings: are they of value to patients,
treating staff or a political additional drain on healthcare
resources? Curr Opin Otolaryngol Head Neck Surg 2008; 16:
103-7.
26. Pivot X, Felip E. Squamous cell carcinoma of the head
and neck: ESMO clinical Recommendations for diagnosis,
treatment and follow-up. Ann Oncol 2008;19 Suppl 2:ii79-
80.
27. NCCN Practice Guidelines in Oncology: Head and Neck
Cancers (www.nccn.org/professionals/physician_gls/PDF/
head-and-neck.pdf).
28. Diagnosis and management of head and neck cancer. A
national clinical guideline. Scottish Intercollegiate Guidelines
Network. Edinburgh (www.sign.ac.uk/pdf/sign90.pdf);
2006.
29. ESMO Clinical Recommendations. Squamous cell carcinoma
of the head and neck. http://annonc.oxfordjoumals.org/
cgi / content / f ull / 20 / suppl_4 / i v121.2009.
30. Ferlito A, Rinaldo A, Silver CE, et al. Neck dissection: then
and now. Auris Nasus Larynx 2006; 33: 365-74.
31. Martin A, Jackel MC, Christiansen H, Mahmoodzada
M, Kron M, Steiner W. Organ preserving transoral laser
microsurgery for cancer of the hypopharynx. Laryngoscope
2008; 118: 398-402.
32. Hinni ML, Salassa JR, Grant DG, et al. Transoral
laser microsurgery for advanced laryngeal cancer. Arch
Otolaryngol Head Neck Surg 2007; 133:1198-204.
33. Steiner W, Vogt P, Ambrosch P, Kron M. Transoral carbon
dioxide laser microsurgery for recurrent glottic carcinoma
after radiotherapy. Head Neck 2004; 26: 477-84.
34. Jacobson AS, Woo P, Shapshay SM. Emerging technology:
flexible C02 laser WaveGuide. Otolaryngol Head Neck Surg
2006; 135:469-70.
35. Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and
neck cancer. Lancet 2008; 371:1695-709.
36. Kao J, Lavaf A, Teng MS, Huang D, Genden EM. Adjuvant
radiotherapy and survival for patients with node-positive
head and neck cancer: an analysis by primary site and nodal
stage. Int J Radiat Oncol Biol Phys 2008; 71: 362-70.
37. Pignon JP, le Maitre A, Bourhis J. Meta-Analyses of
Chemotherapy in Head and Neck Cancer (MACH-NC): an
update. Int J Radiat Oncol Biol Phys 2007; 69:S112-114.
38. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus
cetuximab for squamous-cell carcinoma of the head and
neck. N Engl J Med 2006; 354: 567-78.
39. Winquist E, Oliver T, Gilbert R. Postoperative chemo-
radiotherapy for advanced squamous cell carcinoma of the
head and neck: a systematic review with meta-analysis. Head
Neck 2007; 29: 38-46.
40. Bemier J, Cooper JS, Pajak TF, et al. Defining risk
levels in locally advanced head and neck cancers: a
comparative analysis of concurrent postoperative radiation
plus chemotherapy trials of the EORTC (#22931) and RTOG
(# 9501). Head Neck 2005; 27: 843-50.
41. Cmz JJ, Ocana A, Navarro M, Barco ED, Fonseca E. New
options in the treatment of locally advanced head and neck
cancer: role for induction chemotherapy. Cancer Treat Rev
2008; 34: 268-74.
42. Mamr S, Forastiere AA. Head and neck cancer: changing
epidemiology, diagnosis, and treatment. Mayo Clin Proc
2008; 83: 489-501.
43. Choong N, Vokes E. Expanding role of the medical oncologist
in the management of head and neck cancer. CA Cancer J Clin
2008; 58: 32-53.
44. Vermorken JB, Herbst RS, Leon X, Amellal N, Baselga J.
Overview of the efficacy of cetuximab in recurrent and/or
metastatic squamous cell carcinoma of the head and neck
in patients who previously failed platinum-based therapies.
Cancer 2008; 112: 2710-9.
45. Vermorken JB, Mesia R, Rivera F, et al. Platinum-based
chemotherapy plus cetuximab in head and neck cancer. N
Engl J Med 2008; 359:1116-27.
46. Jereczek-Fossa BA, Orecchia R. Radiotherapy-induced
mandibular bone complications. Cancer Treat Rev 2002; 28:
65-74.
47. Makitie AA, Pukkila M, Laranne J, et al. Oropharyngeal
carcinoma and its treatment in Finland between 1995-1999: a
nationwide study. Eur Arch Otorhinolaryngol 2006; 263:139-
43.
48. Hoffman HT, Kamell LH, Shah JP, et al. Hypopharyngeal
cancer patient care evaluation. Laryngoscope 1997; 107:1005-
17.
49. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette
L, Sahmoud T. Larynx preservation in pyriform sinus cancer:
preliminary results of a European Organization for Research
and Treatment of Cancer phase III trial. EORTC Head and
Neck Cancer Cooperative Group. J Natl Cancer Inst 1996; 88:
890-9.
50. Pfister DG, Laurie SA, Weinstein GS, et al. American Society
of Clinical Oncology clinical practice guideline for the use of
larynx-preservation strategies in the treatment of laryngeal
cancer. J Clin Oncol 2006; 24: 3693-704.
51. Induction chemotherapy plus radiation compared with
surgery plus radiation in patients with advanced laryngeal
cancer. The Department of Veterans Affairs Laryngeal Cancer
Study Group. N Engl J Med 1991; 324:1685-90.
52. Forastiere AA, Goepfert H, Maor M, et al. Concurrent
chemotherapy and radiotherapy for organ preservation in
advanced laryngeal cancer. N Engl J Med 2003; 349: 2091-8.
53. Ganly I, Patel S, Matsuo J, et al. Postoperative complications
of salvage total laryngectomy. Cancer 2005; 103: 2073-81.